Icon Group marked a major step forward in advancing cancer care across Southeast Asia, launching the first stereotactic radiotherapy (SRT) service in Icon Cancer Centre at Bali International Hospital (BIH), in addition to the centre delivering the first brachytherapy patient treatment.
This milestone reflects Icon’s ongoing commitment to expanding access to world-class, integrated cancer care in underserved regions. By leveraging its extensive global network, Icon is able to bring advanced treatment capabilities to more communities.
The new centre is uniquely positioned as the first facility of its kind in the region to be fully supported, operated, and quality-assured by Icon Australia and Singapore, ensuring that clinical protocols, patient safety standards, and operational excellence are benchmarked against Icon’s established international framework.